Rajiv Malik is to retire as president of Viatris from 1 April 2024, amid a continuing strategic transformation for the business that was formed by the merger of Mylan and Pfizer’s Upjohn.
Rajiv Malik will retire as president of Viatris and as a company executive from 1 April 2024, the company has announced, as the organization formed through the merger of Mylan and Pfizer’s Upjohn continues to transform itself with a series of divestments.
Malik – who was previously president of Mylan, which he first joined in 2007 after it acquired a controlling stake...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
